Case Comprehensive Cancer Center Clinical Trials
Sponsors / Case Comprehensive Cancer Center
Case Comprehensive Cancer Center is listed as the lead sponsor on 410 clinical trials registered with ClinicalTrials.gov. 47 trials are actively recruiting participants, 18 remain active without open enrollment, and 257 have concluded. 68 of these trials ended early via termination or withdrawal. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. The cumulative planned enrollment figure across all listed trials is 32,672 participants. All figures are drawn directly from ClinicalTrials.gov and updated as sponsors submit revisions.
410
Total Trials
47
Recruiting
18
Other Active
257
Completed
68
Terminated / Withdrawn
32,672
Total Enrollment
Termination reasons: Recruitment41% · Other29% · Funding16% · PI/or_Site7% · Safety4% · Efficacy1%
Recent Terminations
- Breast Reconstruction"Slow accrual"
- Pancreatic Fistula"Principal investigator left the institution."
- Pancreatic Ductal Adenocarcinoma"Slow accrual"
- Diffuse Large B-Cell Lymphoma"Funding unavailable"
- Urothelial Carcinoma"PI preference"
- Myelodysplastic Syndrome (MDS)"Slow Accrual"
- Breast Reconstruction"Principal Investigator left the institution."
- Gynecologic Cancer"PI left institution"
- Non Small Cell Lung Cancer"Slow accrual"
- Opioid Consumption"Workforce shortage"
Active Trials (18 total)
- NCT07129226
- NCT07219472
- NCT06649201
- Glioblastoma PHASE2NCT05607407
- Head and Neck Cancer PHASE2NCT06627270
- Oligometastasis PHASE1NCT07079098
- Acute Lymphocytic Leukemia PHASE2NCT06904482
- NCT06336538
- Glioblastoma PHASE1NCT03514069
- NCT04556045
- NCT05481697
- NCT05590624
- Cyst of Pancreas PHASE3NCT05720338
- NCT06101069
- NCT06290687
- Lung Cancer PHASE2NCT07104630
- Biliary Tract Cancer PHASE2NCT07146646
- Allogeneic Hematopoietic Cell Transplantation EARLY_PHASE1NCT04332341
- NCT06024603
- NCT07110142